Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report

INTRODUCTION: Hepatocellular carcinoma (HCC) accounts for approximately 90% of primary liver cancer and can be caused by well-known risk factors, including infection with hepatitis B and C viruses, alcohol intake, and metabolic syndrome. The overall prognosis remains poor with a median survival of 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Adžić, Gordan, Prejac, Juraj, Pleština, Stjepko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597619/
https://www.ncbi.nlm.nih.gov/pubmed/37881483
http://dx.doi.org/10.3389/fonc.2023.1260989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597619/
https://www.ncbi.nlm.nih.gov/pubmed/37881483
http://dx.doi.org/10.3389/fonc.2023.1260989

Ejemplares similares